LANDI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 89
AS - Asia 39
EU - Europa 21
SA - Sud America 4
Totale 153
Nazione #
US - Stati Uniti d'America 85
SG - Singapore 26
IT - Italia 14
CN - Cina 5
HK - Hong Kong 4
VN - Vietnam 4
BR - Brasile 3
SE - Svezia 3
AR - Argentina 1
AT - Austria 1
CA - Canada 1
CR - Costa Rica 1
FR - Francia 1
LT - Lituania 1
MQ - Martinica 1
MX - Messico 1
UA - Ucraina 1
Totale 153
Città #
San Jose 52
Singapore 19
Ashburn 12
Santa Clara 7
Hong Kong 4
Milan 4
Stockholm 3
Los Angeles 2
Seattle 2
Shanghai 2
Turin 2
Albuquerque 1
Alcobaça 1
Atlanta 1
Beijing 1
Biên Hòa 1
Boardman 1
Brooklyn 1
Burlington 1
Da Nang 1
Dallas 1
Fort-de-France 1
Hanoi 1
Ho Chi Minh City 1
José C. Paz 1
Kent 1
Kyiv 1
Queens 1
Querétaro 1
Recife 1
San José 1
Shenzhen 1
São Paulo 1
Vilnius 1
Totale 132
Nome #
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors 81
Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatment 20
Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER study 16
Comprehensive genomic profiling in solid tumours: Navigating promise, challenges, and pathways to clinical integration 16
Switch from cetuximab to panitumumab during encorafenib-based therapy in BRAF V600E mutated metastatic colorectal cancer: An international multicenter analysis from the AGEO group 13
Total neoadjuvant treatment, non-operative management and radiotherapy-free strategies: New approaches for the management of proficient mismatch repair/microsatellite stable locally advanced rectal cancer. A narrative review and evidence-based algorithm 13
Totale 159
Categoria #
all - tutte 467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20243 0 0 0 0 0 0 0 0 0 0 2 1
2024/202529 0 1 1 1 4 4 0 2 4 1 6 5
2025/2026127 3 1 1 7 5 4 13 8 0 25 55 5
Totale 159